Jungbluth A A, Stockert E, Chen Y T, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Busam K J, Old L J
Ludwig Institute for Cancer Research at Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Br J Cancer. 2000 Aug;83(4):493-7. doi: 10.1054/bjoc.2000.1291.
Cancer/testis (CT) antigens such as those encoded by the MAGE-gene family are expressed in a wide variety of malignant neoplasms. In normal tissues, expression is generally restricted to testis. Current knowledge of the expression pattern of CT antigens is mainly based on mRNA analysis. Little is known about actual protein expression. We previously developed MA454, a monoclonal antibody (mAb) to MAGE-1 recombinant protein. By employing antigen retrieval techniques, we show that MA454 is reactive on formalin-fixed paraffin-embedded tissues. Immunohistochemical (IHC) analysis of a normal tissue panel revealed staining solely in germ cells of testes. A series of 59 lung tumours was co-typed for MAGE-1 expression by RT-PCR and by immunohistochemistry with MA454. MA454 was positive in 19/59 cases (32%). MAGE-1 mRNA was found in 17 of the 54 cases (32%) available for RT-PCR. Of the 19 MA454-reactive tumours, 15 showed a highly heterogeneous pattern of expression. The other 4 MA454 positive cases revealed immunoreactivity in >25% of tumour areas. Of the 53 cases typed for both, mRNA and protein expression, 48 co-typed whereas 5 cases were discrepant, a likely consequence of heterogeneous MAGE-1 expression. The predominantly focal expression of MAGE-1 suggests that this antigen might not be sufficient as a sole target for immunotherapeutic approaches.
癌胚/睾丸(CT)抗原,如由MAGE基因家族编码的那些抗原,在多种恶性肿瘤中表达。在正常组织中,其表达通常局限于睾丸。目前关于CT抗原表达模式的知识主要基于mRNA分析。对于实际的蛋白质表达了解甚少。我们之前开发了MA454,一种针对MAGE-1重组蛋白的单克隆抗体(mAb)。通过采用抗原修复技术,我们发现MA454对福尔马林固定石蜡包埋组织具有反应性。对一组正常组织进行免疫组织化学(IHC)分析显示,仅在睾丸的生殖细胞中有染色。通过RT-PCR和用MA454进行免疫组织化学对59例肺肿瘤进行了MAGE-1表达的联合分型。MA454在19/59例(32%)中呈阳性。在可用于RT-PCR的54例中的17例(32%)中发现了MAGE-1 mRNA。在19例MA454反应性肿瘤中,15例显示出高度异质性的表达模式。其他4例MA454阳性病例在>25%的肿瘤区域显示出免疫反应性。在对mRNA和蛋白质表达均进行分型的53例病例中,48例分型一致,而5例不一致,这可能是MAGE-1表达异质性的结果。MAGE-1主要为局灶性表达,这表明该抗原作为免疫治疗方法的唯一靶点可能并不充分。